Tag: Covid-19
-
Trial Set for Covid-19 Antibodies in Long-Term Care
Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care.
-
Covid-19 Vaccines, Therapies – 3 August 2020
The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively.
-
Infographic – An Ounce of Pandemic Prevention
A recent journal article estimates the public investments needed to prevent the next damaging pandemic, against the costs imposed on the world from Covid-19.
-
NIH Issues Contracts for Faster Covid-19 Diagnostics
National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays.
-
A.I. Employed for Local Covid-19 Prediction Models
Computer scientists in California are writing deep learning algorithms that generate forecasts for Covid-19 infections in local communities.
-
Two Covid-19 Vaccines Show Preclinical Immune Responses
Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks.
-
Trial Testing Lymphoma Drug to Treat Covid-19
A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections.
-
Covid-19 Vaccines, Therapies – 27 July 2020
This week’s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development.
-
Synthetic Protein Designed to Boost Covid-19 Vaccines
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.
-
Trial Testing Point-of-Care Covid-19 Diagnostic
A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour.